BioCryst Pharmaceuticals, Inc. BCRX

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
-$454.74M
Market Cap
$1.99B
Margin of Safety
—
Intrinsic / Market Ratio
-0.23

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

-454.74M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

-454.74M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

-454.74M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

-454.74M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

-454.74M USD

from the sum above

Market Cap

1.99B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

-0.23×

the ratio the screener ranks by; Margin of Safety — (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: -454.74M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).

The earnings power value was not computed (a normalized NOPAT at or below zero), so the value is the book value today, -454.74M USD.

Market value

Market Cap1.99B USD

Today's price times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): -454.74M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, -454.74M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap1.99B USD

Today's price times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): -454.74M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, -454.74M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap1.99B USD

Today's price times the shares.

Value vs market

Margin of Safety—

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 8.37%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.55×Market Risk Premium 6.00%= 7.79%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 3.53M USDPretax Income 267.66M USD= 1.32%

The tax the interest saves.

Interest Expense =EBIT 346.61M USD−Pretax Income 267.66M USD= 78.95M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 78.95M USDTotal Debt 793.63M USD×(1 − Tax Rate for WACC 1.32%)= 9.82%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 793.63M USDMarket Cap + Total Debt 1.99B USD + 793.63M USD= 28.51%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 71.49%×Cost of Equity 7.79%+Debt Weight 28.51%×Cost of Debt 9.82%= 8.37%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 558.41M USD − Total Liabilities 1.01B USD = Book Value Today -454.74M USD

Total Debt 793.63M USD − Cash and Short-Term Investments 352.93M USD = Net Debt Today 440.70M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 124.1%at most 5%does not pass255,265,000 / 205,771,000
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets15.0%at least -10.0%passes(347.72M USD − 264.12M USD) ÷ 558.41M USD
Price to bookMarket Cap ÷ Book Value Today—at most 3×not measured1.99B USD ÷ -454.74M USD
Operating marginOperating Income ÷ Revenue39.0%above 10.0%passes341.33M USD ÷ 875.71M USD
Revenue growthRevenue ÷ Revenue a Year Before − 194.1%above 10.0%passes875.71M USD / 451.16M USD
Net cash(Cash − Total Debt) ÷ Market Cap-32.1%above -30%does not pass(155.13M USD − 793.63M USD) ÷ 1.99B USD
Operating efficiencyOperating Income ÷ Gross Profit39.8%above 25.0%passes341.33M USD ÷ 856.62M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

8 USD

Enterprise value

2.47B USD

market cap plus net debt

EV / EBITDA

5.71×

Price / book

-4.37×

the provider's book

Price / earnings

—

Return on equity

—

the provider's, not the engine's

Profit margin

-40.9%

Revenue growth

33.6%

Analyst target, mean

21 USD

Analysts

11

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

271.10M331.74M451.16M875.71M

Gross profit

264.50M327.26M438.88M856.62M

Operating income

-148.58M-103.81M-2.55M341.33M

EBITDA

operating income before depreciation and amortisation

-144.00M-116.45M12.82M348.00M

Pretax income

-244.63M-226.46M-87.04M267.66M

Net income

-247.36M-226.77M-88.97M264.12M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-245.79M-203.00M-88.46M281.45M

R&D

253.55M216.78M174.81M166.29M
Balance sheet, year end

Total assets

550.55M517.48M490.91M514.67M

Total liabilities

845.44M973.46M967.32M633.94M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

-294.89M-455.98M-476.41M-119.27M

Total debt

742.19M825.97M809.55M439.31M

Cash and equivalents

305.07M110.75M104.82M89.83M

Net PP&E

fixed assets after depreciation

8.63M20.93M19.80M19.00M

Working capital

current assets less current liabilities

411.40M346.32M261.85M208.49M
Cash flow

Operating cash flow

-162.01M-95.24M-52.07M347.72M

Capital expenditure

paid out, so below zero

-1.35M-2.17M-1.13M-2.47M

Depreciation and amortisation

1.44M1.66M1.25M1.39M

Free cash flow

operating cash flow plus capital expenditure

-163.36M-97.41M-53.20M345.25M